Ani Pharmaceuticals (ANIP) Tax Rate (2012 - 2026)
Ani Pharmaceuticals (ANIP) posted Tax Rate of 26.68% for Q1 2026, up 112.37% sequentially from 12.56% in Q4 2025, and up 516.0% YoY from 4.33% in Q1 2025.
Ani Pharmaceuticals (ANIP) Tax Rate (2012 - 2026) Analysis & Trends
Ani Pharmaceuticals has reported Tax Rate for 15 years, with the latest figure at 26.68% in Q1 2026.
- Quarterly Tax Rate rose 516.0% year-over-year to 26.68% in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 20.57% (down 298.0% YoY) and the FY2025 annual result came in at 18.22%, up 161.0% from the prior year.
- Tax Rate improved to 26.68% in Q1 2026 per ANIP's latest filing, from 12.56% in the prior quarter.
- Over five years, Tax Rate peaked at 32.33% in Q1 2023 and troughed at 21.86% in Q4 2023.
- A 5-year average of 17.59% and a median of 21.95% in 2022 frame the typical range for Tax Rate.
- The sharpest annual moves came in 2023 and 2024: Tax Rate sank 4762 bps in 2023, then surged 4722 bps in 2024.
- Over 5 years, Tax Rate stood at 25.76% in 2022, then slumped by 185 bps to 21.86% in 2023, then jumped by 216 bps to 25.36% in 2024, then tumbled by 50 bps to 12.56% in 2025, then soared by 112 bps to 26.68% in 2026.
- According to Business Quant data, Tax Rate over the past three periods registered 26.68%, 12.56%, and 21.25% for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Tax Rate (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.83 Bn | 42.86 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 42.87 Bn | 39.22 Bn | 2.15 Bn | -26.59% |
| 3 | Zoetis | 31.41 Bn | 29.73 Bn | 1.05 Bn | - |
| 4 | Takeda Pharmaceutical | 28.55 Bn | 22.75 Bn | 5.10 Bn | -30.40% |
| 5 | United Therapeutics | 22.08 Bn | 19.42 Bn | 683.80 Mn | 10.65% |
| 6 | Viatris | 18.73 Bn | 17.84 Bn | 1.46 Bn | -85.63% |
| 7 | Neurocrine Biosciences | 15.44 Bn | 15.05 Bn | 935.80 Mn | 10.97% |
| 8 | Elanco Animal Health | 11.75 Bn | 11.22 Bn | 798.00 Mn | 3.57% |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.94 Bn | - | - |
| 10 | Ani Pharmaceuticals | 1.64 Bn | 1.28 Bn | 165.89 Mn | 33.43% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 33.43% |
| Jun 30, 2026 | 33.43% |
| Jun 30, 2026 | 33.43% |
| Mar 31, 2026 | 26.68% |
| Mar 31, 2026 | 26.68% |
| Mar 31, 2026 | 26.68% |
| Dec 31, 2025 | 12.56% |
| Dec 31, 2025 | 12.56% |
| Dec 31, 2025 | 12.56% |
| Sep 30, 2025 | 21.25% |
| Sep 30, 2025 | 21.25% |
| Sep 30, 2025 | 21.25% |
| Jun 30, 2025 | 19.00% |
| Jun 30, 2025 | 19.00% |
| Jun 30, 2025 | 19.00% |
| Mar 31, 2025 | 21.51% |
| Mar 31, 2025 | 21.51% |
| Mar 31, 2025 | 21.51% |
| Dec 31, 2024 | 25.36% |
| Dec 31, 2024 | 25.36% |